Bulletin du cancer

Keyphrases

Publications

volume 110, number 2S, 2023

Alexandre Thibault Jacques Maria, Arnaud Campidelli, Cristina Castilla-Llorente, Pauline Lansiaux, Zora Marjanovic, Grégory Pugnet, Jose Miguel Torregrosa-Diaz, Louis Terriou, Jean-Pierre Algayres, Fanny Urbain, Ibrahim Yakoub-Agha, Dominique Farge
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]. Bulletin du cancer 110 (2S) (2023)
Alexandre Thibault Jacques Maria, Arnaud Campidelli, Cristina Castilla-Llorente, Pauline Lansiaux, Zora Marjanovic, Grégory Pugnet, Jose Miguel Torregrosa-Diaz, Louis Terriou, Jean-Pierre Algayres, Fanny Urbain, Ibrahim Yakoub-Agha, Dominique Farge
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]. Bulletin du cancer 110 (2S) (2023)

volume 110, number 3, 2023

Marie-Bérengère Troadec, Françoise Porteu, Marie-Laure Arcangeli, Adlen Foudi, Dominique Bluteau, Paulo De Sepulveda, Christel Guillouf, Nathalie M Mazure, Fabienne Meggetto, Philippe Brunet De La Grange, Cyril Broccardo
From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis. Bulletin du cancer 110 (3) (2023)
Ondine Messéant, Guillaume Manson
[Drug approval: Axicabtagene ciloleucel (CAR-T cells) in diffuse large B cell lymphoma after one prior line of therapy]. Bulletin du cancer 110 (3) (2023)
Alix Borderiou, Alexis Astruc, Emmy Saab, Frédéric Chevallier
[Can computer alerts in general practitioners' software upgrade cancer screening participation? A monocentric randomized study in France]. Bulletin du cancer 110 (3) (2023)
François Blot, Margot Fremaux, Christine Mateus
[End of life and cancer: Understanding the ethical issues of voluntary assisted dying]. Bulletin du cancer 110 (3) (2023)
Anne Tenaillon, Daniel Orbach
[Drug approval: Crizotinib in unresectable or refractory ALK-positive pediatric inflammatory myofibroblastic tumors]. Bulletin du cancer 110 (3) (2023)
Chloé Desmaison, Patricia Niccoli, Sandrine Oziel Taieb, Marjorie Faure, Jacques Ewald, Jean Izaaryene, Gilles Piana
Transarterial chemoembolization (TACE) for neuroendocrine liver metastasis (NELM): Predictive value of volumetric arterial enhancement (VAE) on baseline MRI. Bulletin du cancer 110 (3) (2023)
Ondine Messéant, Guillaume Manson
[Drug approval: Axicabtagene ciloleucel (CAR-T cells) in diffuse large B cell lymphoma after one prior line of therapy]. Bulletin du cancer 110 (3) (2023)
Caroline Streicher, Fanny Roussin, Cécile Chastang-Chung, Annick Daulange, Laure Vayre
[Oral anticancer drug: Feedback from six years of tripartite consultations in a hospital center]. Bulletin du cancer 110 (3) (2023)
Nianping Chen, Jiang Qian, Dan Wu, Wei Chen, Jiayan Mao, Ying Cai, Mengting Gu
Propofol mediates bone metastasis by regulating PC-derived exosomal miR-142-3p. Bulletin du cancer 110 (3) (2023)
Roxane Meurillon, Amaury Leruste
[Drug approval: Crizotinib for relapsed or refractory, ALK-positive, systemic anaplastic large cell lymphoma in pediatrics]. Bulletin du cancer 110 (3) (2023)
Anne Tenaillon, Daniel Orbach
[Drug approval: Crizotinib in unresectable or refractory ALK-positive pediatric inflammatory myofibroblastic tumors]. Bulletin du cancer 110 (3) (2023)
Florent Drapeau, Gwladys Claustre, Sophie Gaimard, Caroline Rossard
[Preparation of injectable anticancer drugs within chemotherapy preparation unit: What levers are available to optimize and secure production?] Bulletin du cancer 110 (3) (2023)
Roxane Meurillon, Amaury Leruste
[Drug approval: Crizotinib for relapsed or refractory, ALK-positive, systemic anaplastic large cell lymphoma in pediatrics]. Bulletin du cancer 110 (3) (2023)
Runmei Li, Dong Zhang, Baozhu Ren, Shui Cao, Li Zhou, Yanjuan Xiong, Qian Sun, Xiubao Ren
Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer. Bulletin du cancer 110 (3) (2023)
Florent Drapeau, Gwladys Claustre, Sophie Gaimard, Caroline Rossard
[Preparation of injectable anticancer drugs within chemotherapy preparation unit: What levers are available to optimize and secure production?] Bulletin du cancer 110 (3) (2023)
Roxane Meurillon, Amaury Leruste
[Drug approval: Crizotinib for relapsed or refractory, ALK-positive, systemic anaplastic large cell lymphoma in pediatrics]. Bulletin du cancer 110 (3) (2023)
Ondine Messéant, Guillaume Manson
[Drug approval: Axicabtagene ciloleucel (CAR-T cells) in diffuse large B cell lymphoma after one prior line of therapy]. Bulletin du cancer 110 (3) (2023)
Caroline Streicher, Fanny Roussin, Cécile Chastang-Chung, Annick Daulange, Laure Vayre
[Oral anticancer drug: Feedback from six years of tripartite consultations in a hospital center]. Bulletin du cancer 110 (3) (2023)
Alix Borderiou, Alexis Astruc, Emmy Saab, Frédéric Chevallier
[Can computer alerts in general practitioners' software upgrade cancer screening participation? A monocentric randomized study in France]. Bulletin du cancer 110 (3) (2023)
François Blot, Margot Fremaux, Christine Mateus
[End of life and cancer: Understanding the ethical issues of voluntary assisted dying]. Bulletin du cancer 110 (3) (2023)
Nianping Chen, Jiang Qian, Dan Wu, Wei Chen, Jiayan Mao, Ying Cai, Mengting Gu
Propofol mediates bone metastasis by regulating PC-derived exosomal miR-142-3p. Bulletin du cancer 110 (3) (2023)
Chloé Desmaison, Patricia Niccoli, Sandrine Oziel Taieb, Marjorie Faure, Jacques Ewald, Jean Izaaryene, Gilles Piana
Transarterial chemoembolization (TACE) for neuroendocrine liver metastasis (NELM): Predictive value of volumetric arterial enhancement (VAE) on baseline MRI. Bulletin du cancer 110 (3) (2023)
Olivier Trédan, Caroline Robert, Antoine Italiano, Fabrice Barlesi
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]. Bulletin du cancer 110 (3) (2023)
Olivier Trédan, Caroline Robert, Antoine Italiano, Fabrice Barlesi
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]. Bulletin du cancer 110 (3) (2023)
Anne Tenaillon, Daniel Orbach
[Drug approval: Crizotinib in unresectable or refractory ALK-positive pediatric inflammatory myofibroblastic tumors]. Bulletin du cancer 110 (3) (2023)
Marie-Bérengère Troadec, Françoise Porteu, Marie-Laure Arcangeli, Adlen Foudi, Dominique Bluteau, Paulo De Sepulveda, Christel Guillouf, Nathalie M Mazure, Fabienne Meggetto, Philippe Brunet De La Grange, Cyril Broccardo
From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis. Bulletin du cancer 110 (3) (2023)
Runmei Li, Dong Zhang, Baozhu Ren, Shui Cao, Li Zhou, Yanjuan Xiong, Qian Sun, Xiubao Ren
Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer. Bulletin du cancer 110 (3) (2023)

volume 110, number 5, 2023

Matthieu Delaye, Gilles L'Allemain, Jacques-Olivier Bay
[Artificial intelligence and scientific publications: Desirable, indispensable or to be banned?] Bulletin du cancer 110 (5) (2023)
Matthieu Delaye, Gilles L'Allemain, Jacques-Olivier Bay
[Artificial intelligence and scientific publications: Desirable, indispensable or to be banned?] Bulletin du cancer 110 (5) (2023)
Matthieu Delaye, Gilles L'Allemain, Jacques-Olivier Bay
[Artificial intelligence and scientific publications: Desirable, indispensable or to be banned?] Bulletin du cancer 110 (5) (2023)

volume 110, number 6S, 2023

Frédéric Selle, Florence Joly, Laurence Gladieff, Karine Prulhière, Alexandra Leary, Elsa Kalbacher, Etienne Rouleau, Isabelle Ray-Coquard
Bulletin du cancer 110 (6S) (2023)
Alejandra Martínez, Cyrus Chargari, Elsa Kalbacher, Anne-Lise Gaillard, Alexandra Leary, Martin Koskas, Nicolás Chopin, Anne-Agathe Serre, Anne-Claire Hardy-Bessard, Chérif Akladios, Fabrice Lecuru
Bulletin du cancer 110 (6S) (2023)
Jérôme Alexandre, Marie-Aude Le Frère-Belda, Antoine Angelergues, Gwenaël Ferron, Isabelle Treilleux, Anne-Lise Gaillard, Jean-Sébastien Frenel, Benoît You, Etienne Rouleau, Alain Lortholary, Isabelle Ray-Coquard, Florence Joly, null null
Bulletin du cancer 110 (6S) (2023)

Bulletin du cancer

Keyphrases

Publications

2023

volume 110, number 1, 2023

volume 110, number 11, 2023

volume 110, number 2, 2023

volume 110, number 2S, 2023

volume 110, number 3, 2023

volume 110, number 5, 2023

volume 110, number 6S, 2023